Cryptococcal meningitis in a patient with undiagnosed HIV infection
Authors:
K. Povolná 1; S. Snopková 1; P. Husa 1; Z. Čermáková 2; M. Freibergerová 1; R. Pařízková 1; M. Šnelerová 1; A. Hajná 1
Authors place of work:
Klinika infekčních chorob Lékařské fakulty MU a FN Brno
Přednosta: prof. MUDr. Petr Husa, CSc.
1; Klinika biochemie Lékařské fakuty MU a FN Brno
Primář: doc. MUDr. Milan Dastych, CSc.
2
Published in the journal:
Prakt. Lék. 2008; 88(11): 654-656
Category:
Case Report
Summary
Cryptococcus neoformans is an opportunistic pathogen, which affects individuals who are severely immunosuppressed for any number of reasons. Before the introduction of antiretroviral therapy and antimycotic Fluconazole this pathogen had occurred in 10 % of patients with advanced HIV infection. Nowadays, this disease primarily affects patients with so far undiagnosed, thus untreated, severe immunosuppression. The patient outlined here presented with so far undiagnosed HIV infection, nevertheless, patients can be affected following severe induced immunosuppression - particularly following transplantation. The disease is typified by a gradual onset of non-specific symptoms. Often, a headache or a temperature can be the only manifestation of the disease. For this reason, a delay can frequently occur in diagnosing patients with undiagnosed immunosuppression. The diagnosis is verified by confirmation of the pathogen by latex agglutination of cryptococcal capsular antigen and by cultivation. Amphotericin B is the first-choice therapy. Relatively frequent side-effects are the reason for the change of therapy to the less effective Fluconazole. Sensory dysfunction and impaired consciousness are two of the unfavourable prognostic factors that were noticed in the presented patient. The prognosis of the disease is always severe, and in spite of properly introduced therapy, the mortality rate is 10 %. Relapses and the latent survival of the pathogen in the prostate gland are possible.
Key words:
Cryptococcal meningitis, Cryptococcus neoformans, immunosuppression, HIV infection.
Zdroje
1. Černý, R., Machala, L. Neurologické komplikace HIV/AIDS. 1. vyd. Praha: Karolinum, 2007. 303 s. ISBN 978-80-246-1222-5.
2. Gorbach, S.L., Falagas, M. The 5-minute infectious diseases consult. USA: Lippincott Williams and Wilkins, 2001. ISBN 0-683-30736-3, p. 144-145.
3. Hoffmann, C., Rockstroh, J.K., Kamps, B.S., HIV medicine 2007. 15. ed. Paris: Flying Publisher, 2007. 818 p. ISBN 3-924774-59-5
4. Rozsypal, H. AIDS klinický obraz a léčba. 1. vyd. Praha: Maxdorf, 1998. 236 s. ISBN 80-85800-92-6.
5. Sharkey, P., Graybill, J. Larsen, R. et al. Amphotericin B lipid komplex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis. 1996, 22, p. 315-321.
6. Singh, C.S., Rahman, M., Jamil, S. et al. Cholecystitis as the initial manifestation of disseminated cryptococcosis. AIDS, 2007, 21, 15, p. 2111-2117. ISSN 0269-9370
7. Snopková, S., Chalupa, P. Postižení plic u infekce HIV/AIDS. In: Záněty plic v intenzivní medicíně. 1.vyd. Praha: Galén, 2004. 189 s. ISBN 80-7262-278-1.
8. Vibhagool, A., Sungkanuparph, S., Mootsikapun, P. et al. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human-imunodeficiency virus- infected patiens treated with highly active antiretroviral therapy: a prospective multicenter, randomized study. Clin. Infect. Dis. 2003, 36, p. 1329-1331.
Štítky
General practitioner for children and adolescents General practitioner for adultsČlánok vyšiel v časopise
General Practitioner
2008 Číslo 11
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Memantine Eases Daily Life for Patients and Caregivers
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
Najčítanejšie v tomto čísle
- Cryptococcal meningitis in a patient with undiagnosed HIV infection
- HIV encephalopathy
- Pneumocystis pneumonia in a patient with newly diagnosed chronic retroviral infection
- Current options for active immunization of HIV infected patients